Hemogenyx Pharmaceuticals LLC
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public, Subsidiary
- Established
- 2013-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.hemogenyx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML
Phase 1
Recruiting
- Conditions
- Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
- Interventions
- Drug: Anti-FLT3 CAR-T cells
- First Posted Date
- 2025-01-22
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Hemogenyx Pharmaceuticals LLC
- Target Recruit Count
- 18
- Registration Number
- NCT06786533
- Locations
- 🇺🇸
MD Anderson, Houston, Texas, United States
News
No news found